ULTRACE services

OUR SERVICES

These are the main topics we could support you on

Strategy

Project &
Operations

Pre-clinical
& Clinical

CMC

Regulatory
& Audit

Business
& Alliance

Strategy

  • Situating your concept in the state-of-art and future perspective of medical and societal needs and expectations which may entail the elaboration of a very preliminary Target Product Profile
  • Defining a pre-project and its preliminary specifications
  • Conducting feasibility studies, interacting / validating with reliable experts (on an international basis), setting cost and time estimates, delineating options, and making simulations
  • Defining or supporting the Global Development Strategy (including alternative options) up to Proof-of-Concept, or beyond as needed (Market Authorization, Pre-Launch, Launch), with costing, timing and definition of milestones and go / nogo decision points and criteria. This results in Development Plan writing
  • Defining or supporting the Market Access Strategy, value-based pricing and alternative approaches
  • Building SWOTs, driving competitive intelligence and analysis (marketed products /drugs in development), gathering the relevant epidemiologic data, building patient-trees
  • Writing and updating the Target Product Profile, market positioning, and life cycle management plan.
  • Supporting Business Plan development and/or validation
  • Bringing scientific support to IP generation, issues, strength of patents, freedom to operate (FTO)
  • Supporting Due Diligence preparation, organization and conduct
  • Interacting with current or potential partners in the perspective of alliances, acquisitions, exit and partnerships

Project & Operations

Either Full R&D (Global) – Pre-clinical – CMC – or Clinical – Project management

Operationalizing Development Activities

  • Leading the declination and itemization of the Development Plan into detailed work packages
  • Supporting or leading the step-by-step execution of Operations with the company cross functional multidisciplinary expert team and/or vendor organizations, and other consultants, depending on organizational structure and means
  • Project steering, planning /priorities definition, development of KPIs and monitoring tools, risk management to support decision making and management or Board visibility on advancement
  • Following-up on actions, decisions, building remediation plans
  • Reviewing assessing project deliverables (based on multiple references), and checking alignment with strategy and planning.
  • Managing or checking on Budget (internal and outsourced)
  • Preparing or supporting presentations and communications to the Executive Board, Partners, decision-making Committees, and other third parties

Organization – Working Style

  • Supporting, initiating or leading the switch into project mode (as necessary)
  • Supporting Portfolio Management and interaction between projects, with resource arbitration where needed
  • Project team coaching and training , support to the hiring process
  • Coaching and mentoring of managers and colleagues in the development and execution of action plans, follow-up and evaluation

Pre-clinical & Clinical

  • Designing and overseeing the implementation of the clinical development plan, identifying the critical steps and roadblocks, defining alternative options
  • Conducting bibliographic analysis, literature search and extractions, driving international expert mapping
  • Writing / validating study synopsis, interacting with area experts
  • Reviewing, amending, overseeing clinical and regulatory documentation preparation for phase 1 to 4 clinical trials (Investigator’s brochure, protocol, IMPD, ICF, CRF…)
  • Hiring Clinical Team, and on a need basis training it to GCP, methodology, practical conduct of trials, safety, drug supply chain, etc…
  • Selecting, contracting and overseeing pre-clinical or clinical vendors: CROs, SMOs, clinical supplies manufacturers, statisticians, data managers, regulatory or pharmacovigilance services
  • Setting up Steering Committees, Advisory Boards, DSMBs, and managing contracts as appropriate
  • Supporting, preparing, attending interactions with Regulatory Agencies and other entitled Authorities
  • Developing clinical research contracts with investigators, hospitals and institutions and with multiple parties
  • Managing, validating medical and clinical communication with stakeholders

CMC

  • Preparation of the CMC development plan from Cell Line Development to Clinical Batch
  • Selection of and contract with CMOs (RFP, Scope of work, Service Agreement…)
    – Drug Substance / Drug Product
    – Subcontractors for Viral safety, Fill & Finish, Packaging, Batch Release…
  • Management of all CMC activities
    – Process Development
    – Formulation establishment
    – Process scale up and GMP material manufacturing
    – Establishment and qualification of analytical methods
    – Stability studies
    – Release of Drug Substance/Drug Product
  • Preparation of tools and decision making process
  • Transition to GLP toxicology studies and clinical

Regulatory & audit

  • Preparing and filing authorization applications to the Ethics Committees and competent authorities
  • Preparing, attending and following-up on meetings with the Authorities and other regulatory, Ethics, or scientific bodies in the EU and US territories, supporting as needed for other oversee applications (e.g. ensuring of consistency)
  • Preparing and/or evaluating dossiers for Orphan Medicinal Product Designations (EU) / Orphan Drug Designation (US)
  • Reviewing IMPD, IB, participating to Scientific Advice meetings
  • Organizing and preparing for submissions to Health authorities (EMA)
  • Seeking advice on scientific and technical regulations

Business & Alliances

  • Helping companies or investors on strategic missions, project, product, and resource evaluations
  • Developing or supporting applications for public subsidies and grants (H2020, EU, national or US public funds, specialized funds e.g. Carb-X)
  • Supporting Due Diligence efforts (for both in and outlicensing)
  • Supporting Funds Raising communication, attending and following-up on meetings with investors
  • Supporting the search for adequate partnerships or collaborations

ULTRace holds an agreement in France for companies that can benefit from Research Tax Credit for R&D qualifying missions.